Ablation after ICD Implantation — Bridging the Gap between Promise and Practice  

Oleh:

Estes, N.A. Mark

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The New England Journal of Medicine (keterangan: ada di Proquest) vol. 357 no. 26 (Dec. 2007), page 2717.

Ketersediaan

Perpustakaan FK Nomor Panggil: N08.K.2007.06 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Reddy, V. Y. PubMed Citation Sudden cardiac arrest due to acute ventricular tachyarrhythmia remains the most common cause of death in developed nations and accounts for more than 450,000 deaths annually in the United States.1,2 Most patients who have a sudden cardiac arrest have coronary artery disease and impaired left ventricular function.1,2 Appropriately designed prospective, randomized trials involving such patients after they have had a myocardial infarction have demonstrated a neutral or harmful effect on survival from the use of antiarrhythmic drugs.1 In contrast, studies have consistently demonstrated a survival benefit from the implantable cardioverter–defibrillator (ICD).1,2,3,4 These conclusions have been reached by means of rigorous . . .

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali